ACK
ABBV icon

Andrew C. Karlinski’s AbbVie ABBV Stock Holding History

Andrew C. Karlinski’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-80
Closed -$11K – 3
2022
Q3 		$11K Sell
80
-8
-9% -$1.15K 0.02% 152
2022
Q2 		$13K Sell
88
-2
-2% -$306 0.02% 156
2022
Q1 		$15K Hold
90
– – 0.03% 147
2021
Q4 		$12K Buy
+90
New +$10.6K 0.02% 127

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Andrew C. Karlinski's ABBV Position: Q4 2022 in Review

Andrew C. Karlinski sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 80 shares — an estimated $11K sold.

Andrew C. Karlinski first reported a position in ABBV in Q4 2021 and held it in 4 quarters. The position peaked at $15K in Q1 2022. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Andrew C. Karlinski reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
  • Andrew C. Karlinski sold 80 AbbVie shares in Q4 2022, an estimated $11K.
  • Andrew C. Karlinski first reported a position in AbbVie in Q4 2021 and held it in 4 quarters.
  • Andrew C. Karlinski's AbbVie position peaked at $15K in Q1 2022.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Andrew C. Karlinski's 13F filing for Q4 2022.